Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PLSIA (Premier Laser Systems) -- Ignore unavailable to you. Want to Upgrade?

To: Pluvia who wrote (1368)	12/5/1997 4:26:00 PM
From: Mama Bear	Read Replies (1) \| Respond to of 1773

Nice that you can post a trade a month and a half after the fact and try to take the credit. BTW, whatever did happen to that "real money" portfolio in the Shark Attack you used to crow about? That's a rhetorical question Steve, I'm sure the people on this thread are sick of this inane conversation by now. Barb

To: Pluvia who wrote (1368)	12/6/1997 1:26:00 AM
From: Pluvia	Respond to of 1773

*My response to Gecko on AOL* Mr. Gecko, <<<I also asked Mr. Pluvia to comment on the hand held corneal topograhy laser that just received FDA approval and he is mysteriously silent on this and the surgical laser which will end the need for stiches after surgery.>>> Actually I did comment on this but the comment was lost in an apparent AOL glitch last weekend. I haven't had time since to re-write that response, but since you asked -- here are my thoughts. Firstoff, these most recent new products are IMO important to consider, because IMO so far the products which constitute the majority of this company's revenue are the Dental Drill and the whiting/curing lasers. Thus far IMO, the company has spent a great deal of time and money developing products -- as evidenced by this from the last filing: ** snip* "As of March 31, 1997, the Company had an accumulated deficit of approximately $24.2 million and tangible net worth of approximately $8.8 million. For the fiscal years ended March 31, 1995, 1996 and 1997, the Company had operating losses of approximately $3.8 million, $5.8 million and $5.6 million, respectively,,,," *snip* and yet they have still only have two significant revenue sources -- the dental drill and the whitening/curing lasers. Two products which according to the last ILT press release on the subject and this from the last PLSIA SEC filing -- they are being sued for patent infringement. *snip* "American Dental Technologies ("ADT") recently has asserted that an aspect of the delivery system of the Company's Er:YAG laser infringes a patent held by ADT." *snip* So I am left asking -- what brilliant decision making led the company to blow 6 years and 24.2 million dollars and only have these IMO, questionable products to show for their efforts? Well I would guess the CEO had some responsibility there. The same CEO that I assume is HYPING the potential of these new wonder products. HYPING them I might add right when they are trying to gain millions from the exercise of their warrants -- gee a coincidence? I don't think so. So Mr. Gecko, to answer your question regarding my thoughts on the opthalmic lasers and the "Black Box" super dooper laser that apparently will make sutures obsolete, I refer you to this from the last filed 10K: *snip* "the Company has received more than 100 clearances from the United States Food and Drug Administration (the "FDA") in multiple specialty areas to market its laser products" *snip* Six years and 24.2 million bucks spent yield two IMO rather questionable products out of "more than 100 clearances from the United States Food and Drug Administration". So, do I think the company's most recent "Wonder Product" hand held cornea gizmo will make the company millions? I'm not going to hold my breath. The company has a history of failures and seems IMO to be lacking the management talent to choose products that have true potential for success. The only thing they have seemed to prove in the last 6 years IMO is they can blow a lot of cash. As far as the wonder suture gizmo -- IMO this sounds like a typical HYPE job to get investors frothy just at a time when the company is trying to prop it's stock price up to gain millions from the exercise of their warrants. I know a bit about the medical industry Mr. Gecko -- and I can tell you -- expensive new products -- i.e. multi thousand dollar lasers to replace a $9 suture set IMO have no chance of making much money in the current cost containment medical atmosphere. Insurance companies will IMO not pay the higher expense the procedure would require and thus IMO the product would never make it in the market place. It does make for a nice "STORY" for you to dream about though -- a nice "STORY" to use as HYPE to prop up a stock right when you want to exercise millions of dollars of warrants. Cheers Steve

To: Pluvia who wrote (1368)	12/6/1997 1:30:00 AM
From: Pluvia	Respond to of 1773

Gecko, Here's some additional info from the company's last SEC filings about their ophthalmic gizmo that makes me question the potential success of this product: *snip* "EyeSys currently markets a single product (a corneal topography measuring system) in a highly competitive market. Historically, EyeSys has incurred substantial losses." *snip* *snip* "The corneal topography market is highly competitive. There are many companies, both public and private, some with significantly greater resources than EyeSys engaged in the corneal topography market. These companies include Alcon Laboratories (a subsidiary of Nestle), Humphrey Instruments (a subsidiary of Carl Zeiss), and Tomey Technology. These companies, together with EyeSys and others, market corneal topography instruments which utilize a technology for measuring corneal curvature based on reflected images. Other companies, including PAR Technology and Orbtek, utilize other technologies to measure the corneal surface. There can be no assurances that EyeSys' competitors will not succeed in developing technologies, procedures of products that are more effective or economical than those marketed or being developed by EyeSys or that would render EyeSys' products obsolete or noncompetitive." *snip* *snip* "Certain computer memory chips used by EyeSys in its proprietary hardware are manufactured by a single company. These computer memory chips are subject to rapid innovation and obsolescence. The discontinuance of the manufacturing of this chip may require EyeSys to redesign certain hardware and software to accommodate a replacement chip. While in the past EyeSys has been successful in these redesign efforts, there can be no assurance that such an event would not prove costly or cause a disruption in sales of corneal topography systems." *snip* Cheers Steve